Entocort EC, a new ORAL form of budesonide for Crohn's disease

AstraZeneca will soon introduce Entocort EC, a new ORAL form of budesonide for Crohn's disease.

This new steroid is approved for acute flare-ups that involve the ileum and/or ascending colon.

Entocort EC releases budesonide in the small intestine and colon to decrease inflammation.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote